TRIB
Trinity Biotech
TRIB
TRIB
93 hedge funds and large institutions have $318M invested in Trinity Biotech in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $325M → $318M (-$7.13M)
89% less call options, than puts
Call options by funds: $345K | Put options by funds: $3.04M
Holders
93
Holding in Top 10
3
Calls
$345K
Puts
$3.04M
Top Buyers
| 1 | +$6.27M | |
| 2 | +$5.35M | |
| 3 | +$5.31M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$5.26M |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$4.86M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$2.82M | |
| 3 | -$1.82M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.58M |
| 5 |
KPCM
Kings Point Capital Management
Great Neck,
New York
|
-$981K |